Karyopharm Therapeutics (KPTI) Asset Utilization Ratio (2013 - 2026)
Karyopharm Therapeutics' (KPTI) Asset Utilization Ratio was 1.36 for Q2 2026, up 15.3% from 1.18 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Karyopharm Therapeutics was 1.07, up 49.2% from FY2024.
- Asset Utilization Ratio has increased for three consecutive years.
- By year, Asset Utilization Ratio came in at 0.72 in FY2024 (+47.1%), 0.49 in FY2023 (+3.0%), 0.47 in FY2022 (-30.2%) and 0.68 in FY2021 (+90.9%).
- Five-year quarterly Asset Utilization Ratio spans a low of 0.43 in Q1 2023 and a high of 1.43 in Q4 2025.
- The high point for year-over-year Asset Utilization Ratio in five years was Q2 2022 (growth of 150.6%); the low point was Q3 2023 (a decline of 49.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn | 1.36 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 |
| Dec 31, 2025 | 1.43 |
| Sep 30, 2025 | 1.42 |
| Jun 30, 2025 | 1.18 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.82 |
| Sep 30, 2024 | 0.74 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.63 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.51 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 1.02 |
| Jun 30, 2022 | 0.91 |
| Mar 31, 2022 | 0.78 |
| Dec 31, 2021 | 0.75 |
| Sep 30, 2021 | 0.44 |
| Jun 30, 2021 | 0.36 |
API Access
Karyopharm Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();